Due to the fact that CD44 is associated with resistance to treatment and poor prognosis of many cancers [81,82,83,84,85], it is highly desirable to reveal other aspects of the mechanism of action of ATRA in breast cancer. This evidence concerns the gene CD44 and cancer.